#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage III Hyperoxaluria Rheumatoid arthritis Astrocytoma malignant Oesophageal atresia Acute lymphocytic leukaemia recurrent Necrotising enterocolitis neonatal Short stature Hyperinsulinism Cognitive disorder Hairy cell leukaemia Dupuytren's contracture Pancreatic neuroendocrine tumour Breast cancer metastatic Hereditary neuropathic amyloidosis More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Trials in Disease Brain stem glioma – Basic Information Angelman’s syndrome – Diagnostics Erdheim-Chester disease – Life with Disease X-linked lymphoproliferative syndrome – Trials in Disease Rhabdoid tumour – Diagnostics Immunodeficiency congenital – Diagnostics Lysosomal storage disorder – Treatment Bronchiolitis obliterans syndrome – Treatment Congenital hypotransferrinaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cemdisiran Fluindione Ipn01194 Estriol GSKVX000000030825 RNMB3 Phenylephrine Felzartamab Acetylcysteine Amide Disodium Levofolinate Nafarelin Phenobarbital Bepirovirsen TETANUS TOXOID IBUZATRELVIR Betamethasone Dipropionate Sodium Alginate Rigosertib Sodium Telmisartan Mogamulizumab More therapies…

    Learn about Your Condition

    Incontinence Retinal artery occlusion Autoimmune haemolytic anaemia Merycism Type 1 diabetes mellitus Menopause Vitiligo Rhabdoid tumour of the kidney Fallopian tube cancer stage IV Endometrial cancer stage III Injection site pain Migraine without aura Shprintzen-Goldberg syndrome Myeloproliferative neoplasm Endometrial cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Synexus Polska Sp. z o.o.

Synexus Polska Sp. z o.o.

Udg Lzauiji 3ci Gtduerr 8llowts Ptfghq

Want to learn more about this study or check if you can participate? Contact us.

  • Study comparing aciclovir gel and cream effectiveness in treating recurrent cold sores (herpes labialis)

    Recruiting

    3 1 1
    Investigated Drugs:
    • Aciclovir
    Poland

  • Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Efruxifermin
    France Germany Italy Poland Spain

  • Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Calcium Lactate Gluconate
    • Calcium Carbonate
    • Colecalciferol
    Bulgaria Estonia Hungary Latvia Poland Slovakia

  • Study of NT 201 compared to placebo in adults with moderate to severe platysma prominence

    Not recruiting

    3 1
    Investigated Diseases:
    • Muscle hypertrophy
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    France Germany Poland Spain

  • Study on the Safety and Immune Response of JNJ-78901563 and High-dose Influenza Vaccine in Preventing E. coli Infections in Adults Aged 65 and Older

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Escherichia infection
    Investigated Drugs:
    • Ecoo15
    • Ecoo16
    • Ecoo18A
    Belgium Poland

  • Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study on Botulinum Toxin Type A for Preventing Chronic Migraine in Adults

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Czechia Germany Italy Poland Spain

  • Study on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Czechia France Germany Poland Spain

  • Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    • Paracetamol
    Bulgaria France Germany Hungary Poland Spain

  • Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

    Not recruiting

    3 1
    Investigated Drugs:
    • Astegolimab
    Austria Belgium Bulgaria Czechia Denmark France +10

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!